nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Pentoxifylline—systemic scleroderma	0.192	0.32	CbGbCtD
Cinacalcet—CYP1A2—Leflunomide—systemic scleroderma	0.183	0.305	CbGbCtD
Cinacalcet—CYP2D6—Captopril—systemic scleroderma	0.118	0.197	CbGbCtD
Cinacalcet—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0592	0.0988	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—systemic scleroderma	0.0473	0.079	CbGbCtD
Cinacalcet—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00281	CcSEcCtD
Cinacalcet—Arthralgia—Leflunomide—systemic scleroderma	0.00113	0.00281	CcSEcCtD
Cinacalcet—Chest pain—Leflunomide—systemic scleroderma	0.00113	0.00281	CcSEcCtD
Cinacalcet—Myalgia—Leflunomide—systemic scleroderma	0.00113	0.00281	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00112	0.00279	CcSEcCtD
Cinacalcet—Constipation—Captopril—systemic scleroderma	0.00112	0.00279	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00112	0.00279	CcSEcCtD
Cinacalcet—Skin disorder—Azathioprine—systemic scleroderma	0.00111	0.00277	CcSEcCtD
Cinacalcet—Cough—Mycophenolic acid—systemic scleroderma	0.0011	0.00275	CcSEcCtD
Cinacalcet—Vomiting—Pentoxifylline—systemic scleroderma	0.0011	0.00274	CcSEcCtD
Cinacalcet—Convulsion—Mycophenolic acid—systemic scleroderma	0.00109	0.00273	CcSEcCtD
Cinacalcet—Muscle spasms—Lisinopril—systemic scleroderma	0.00109	0.00272	CcSEcCtD
Cinacalcet—Rash—Pentoxifylline—systemic scleroderma	0.00109	0.00272	CcSEcCtD
Cinacalcet—Hypertension—Mycophenolic acid—systemic scleroderma	0.00109	0.00272	CcSEcCtD
Cinacalcet—Dermatitis—Pentoxifylline—systemic scleroderma	0.00109	0.00271	CcSEcCtD
Cinacalcet—Headache—Pentoxifylline—systemic scleroderma	0.00108	0.0027	CcSEcCtD
Cinacalcet—Chest pain—Mycophenolic acid—systemic scleroderma	0.00107	0.00268	CcSEcCtD
Cinacalcet—Myalgia—Mycophenolic acid—systemic scleroderma	0.00107	0.00268	CcSEcCtD
Cinacalcet—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00107	0.00268	CcSEcCtD
Cinacalcet—Infection—Leflunomide—systemic scleroderma	0.00107	0.00267	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Captopril—systemic scleroderma	0.00107	0.00267	CcSEcCtD
Cinacalcet—Asthenia—Mometasone—systemic scleroderma	0.00107	0.00267	CcSEcCtD
Cinacalcet—Hypotension—Azathioprine—systemic scleroderma	0.00107	0.00266	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00107	0.00266	CcSEcCtD
Cinacalcet—Nervous system disorder—Leflunomide—systemic scleroderma	0.00106	0.00264	CcSEcCtD
Cinacalcet—Pruritus—Mometasone—systemic scleroderma	0.00105	0.00263	CcSEcCtD
Cinacalcet—Anaemia—Lisinopril—systemic scleroderma	0.00105	0.00262	CcSEcCtD
Cinacalcet—Skin disorder—Leflunomide—systemic scleroderma	0.00105	0.00261	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00104	0.0026	CcSEcCtD
Cinacalcet—Angioedema—Lisinopril—systemic scleroderma	0.00104	0.00259	CcSEcCtD
Cinacalcet—Body temperature increased—Captopril—systemic scleroderma	0.00104	0.00258	CcSEcCtD
Cinacalcet—Abdominal pain—Captopril—systemic scleroderma	0.00104	0.00258	CcSEcCtD
Cinacalcet—Anorexia—Leflunomide—systemic scleroderma	0.00103	0.00257	CcSEcCtD
Cinacalcet—Nausea—Pentoxifylline—systemic scleroderma	0.00103	0.00256	CcSEcCtD
Cinacalcet—Infection—Mycophenolic acid—systemic scleroderma	0.00102	0.00255	CcSEcCtD
Cinacalcet—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00255	CcSEcCtD
Cinacalcet—Diarrhoea—Mometasone—systemic scleroderma	0.00102	0.00254	CcSEcCtD
Cinacalcet—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00101	0.00252	CcSEcCtD
Cinacalcet—Hypotension—Leflunomide—systemic scleroderma	0.00101	0.00251	CcSEcCtD
Cinacalcet—Skin disorder—Mycophenolic acid—systemic scleroderma	0.001	0.00249	CcSEcCtD
Cinacalcet—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000996	0.00248	CcSEcCtD
Cinacalcet—Cough—Lisinopril—systemic scleroderma	0.000992	0.00247	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000987	0.00246	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000983	0.00245	CcSEcCtD
Cinacalcet—Anorexia—Mycophenolic acid—systemic scleroderma	0.000981	0.00245	CcSEcCtD
Cinacalcet—Paraesthesia—Leflunomide—systemic scleroderma	0.000969	0.00242	CcSEcCtD
Cinacalcet—Chest pain—Lisinopril—systemic scleroderma	0.000967	0.00241	CcSEcCtD
Cinacalcet—Arthralgia—Lisinopril—systemic scleroderma	0.000967	0.00241	CcSEcCtD
Cinacalcet—Myalgia—Lisinopril—systemic scleroderma	0.000967	0.00241	CcSEcCtD
Cinacalcet—Dyspnoea—Leflunomide—systemic scleroderma	0.000962	0.0024	CcSEcCtD
Cinacalcet—Hypotension—Mycophenolic acid—systemic scleroderma	0.000962	0.0024	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000961	0.0024	CcSEcCtD
Cinacalcet—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000957	0.00239	CcSEcCtD
Cinacalcet—Dyspepsia—Leflunomide—systemic scleroderma	0.00095	0.00237	CcSEcCtD
Cinacalcet—Vomiting—Mometasone—systemic scleroderma	0.000948	0.00236	CcSEcCtD
Cinacalcet—Rash—Mometasone—systemic scleroderma	0.00094	0.00234	CcSEcCtD
Cinacalcet—Asthenia—Captopril—systemic scleroderma	0.000939	0.00234	CcSEcCtD
Cinacalcet—Dermatitis—Mometasone—systemic scleroderma	0.000939	0.00234	CcSEcCtD
Cinacalcet—Decreased appetite—Leflunomide—systemic scleroderma	0.000938	0.00234	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000938	0.00234	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000934	0.00233	CcSEcCtD
Cinacalcet—Headache—Mometasone—systemic scleroderma	0.000934	0.00233	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000932	0.00232	CcSEcCtD
Cinacalcet—Fatigue—Leflunomide—systemic scleroderma	0.00093	0.00232	CcSEcCtD
Cinacalcet—Pruritus—Captopril—systemic scleroderma	0.000926	0.00231	CcSEcCtD
Cinacalcet—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000924	0.00231	CcSEcCtD
Cinacalcet—Constipation—Leflunomide—systemic scleroderma	0.000923	0.0023	CcSEcCtD
Cinacalcet—Infection—Lisinopril—systemic scleroderma	0.000921	0.0023	CcSEcCtD
Cinacalcet—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00092	0.00229	CcSEcCtD
Cinacalcet—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000918	0.00229	CcSEcCtD
Cinacalcet—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00091	0.00227	CcSEcCtD
Cinacalcet—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000906	0.00226	CcSEcCtD
Cinacalcet—Body temperature increased—Azathioprine—systemic scleroderma	0.000903	0.00225	CcSEcCtD
Cinacalcet—Abdominal pain—Azathioprine—systemic scleroderma	0.000903	0.00225	CcSEcCtD
Cinacalcet—Skin disorder—Lisinopril—systemic scleroderma	0.000901	0.00225	CcSEcCtD
Cinacalcet—Diarrhoea—Captopril—systemic scleroderma	0.000896	0.00223	CcSEcCtD
Cinacalcet—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000895	0.00223	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000889	0.00222	CcSEcCtD
Cinacalcet—Fatigue—Mycophenolic acid—systemic scleroderma	0.000888	0.00221	CcSEcCtD
Cinacalcet—Nausea—Mometasone—systemic scleroderma	0.000886	0.00221	CcSEcCtD
Cinacalcet—Anorexia—Lisinopril—systemic scleroderma	0.000884	0.0022	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000882	0.0022	CcSEcCtD
Cinacalcet—Constipation—Mycophenolic acid—systemic scleroderma	0.00088	0.0022	CcSEcCtD
Cinacalcet—Cough—Mycophenolate mofetil—systemic scleroderma	0.000869	0.00217	CcSEcCtD
Cinacalcet—Hypotension—Lisinopril—systemic scleroderma	0.000867	0.00216	CcSEcCtD
Cinacalcet—Dizziness—Captopril—systemic scleroderma	0.000866	0.00216	CcSEcCtD
Cinacalcet—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000863	0.00215	CcSEcCtD
Cinacalcet—Depression—Prednisone—systemic scleroderma	0.000861	0.00215	CcSEcCtD
Cinacalcet—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00214	CcSEcCtD
Cinacalcet—Urticaria—Leflunomide—systemic scleroderma	0.000857	0.00214	CcSEcCtD
Cinacalcet—Abdominal pain—Leflunomide—systemic scleroderma	0.000853	0.00213	CcSEcCtD
Cinacalcet—Body temperature increased—Leflunomide—systemic scleroderma	0.000853	0.00213	CcSEcCtD
Cinacalcet—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000848	0.00211	CcSEcCtD
Cinacalcet—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000848	0.00211	CcSEcCtD
Cinacalcet—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000848	0.00211	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000845	0.00211	CcSEcCtD
Cinacalcet—Hypersensitivity—Azathioprine—systemic scleroderma	0.000842	0.0021	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000842	0.0021	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000842	0.0021	CcSEcCtD
Cinacalcet—Paraesthesia—Lisinopril—systemic scleroderma	0.000833	0.00208	CcSEcCtD
Cinacalcet—Vomiting—Captopril—systemic scleroderma	0.000833	0.00208	CcSEcCtD
Cinacalcet—Dyspnoea—Lisinopril—systemic scleroderma	0.000827	0.00206	CcSEcCtD
Cinacalcet—Rash—Captopril—systemic scleroderma	0.000826	0.00206	CcSEcCtD
Cinacalcet—Dermatitis—Captopril—systemic scleroderma	0.000825	0.00206	CcSEcCtD
Cinacalcet—Headache—Captopril—systemic scleroderma	0.00082	0.00205	CcSEcCtD
Cinacalcet—Dyspepsia—Lisinopril—systemic scleroderma	0.000816	0.00204	CcSEcCtD
Cinacalcet—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000814	0.00203	CcSEcCtD
Cinacalcet—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000814	0.00203	CcSEcCtD
Cinacalcet—Infection—Mycophenolate mofetil—systemic scleroderma	0.000807	0.00201	CcSEcCtD
Cinacalcet—Decreased appetite—Lisinopril—systemic scleroderma	0.000806	0.00201	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000801	0.002	CcSEcCtD
Cinacalcet—Fatigue—Lisinopril—systemic scleroderma	0.000799	0.00199	CcSEcCtD
Cinacalcet—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00199	CcSEcCtD
Cinacalcet—Hypersensitivity—Leflunomide—systemic scleroderma	0.000795	0.00198	CcSEcCtD
Cinacalcet—Constipation—Lisinopril—systemic scleroderma	0.000793	0.00198	CcSEcCtD
Cinacalcet—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000789	0.00197	CcSEcCtD
Cinacalcet—Diarrhoea—Azathioprine—systemic scleroderma	0.000782	0.00195	CcSEcCtD
Cinacalcet—Nausea—Captopril—systemic scleroderma	0.000778	0.00194	CcSEcCtD
Cinacalcet—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000774	0.00193	CcSEcCtD
Cinacalcet—Asthenia—Leflunomide—systemic scleroderma	0.000774	0.00193	CcSEcCtD
Cinacalcet—Pruritus—Leflunomide—systemic scleroderma	0.000764	0.0019	CcSEcCtD
Cinacalcet—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000759	0.00189	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000758	0.00189	CcSEcCtD
Cinacalcet—Dizziness—Azathioprine—systemic scleroderma	0.000756	0.00188	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000752	0.00188	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00185	CcSEcCtD
Cinacalcet—Asthenia—Mycophenolic acid—systemic scleroderma	0.000739	0.00184	CcSEcCtD
Cinacalcet—Diarrhoea—Leflunomide—systemic scleroderma	0.000738	0.00184	CcSEcCtD
Cinacalcet—Urticaria—Lisinopril—systemic scleroderma	0.000737	0.00184	CcSEcCtD
Cinacalcet—Abdominal pain—Lisinopril—systemic scleroderma	0.000733	0.00183	CcSEcCtD
Cinacalcet—Body temperature increased—Lisinopril—systemic scleroderma	0.000733	0.00183	CcSEcCtD
Cinacalcet—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00073	0.00182	CcSEcCtD
Cinacalcet—Pruritus—Mycophenolic acid—systemic scleroderma	0.000728	0.00182	CcSEcCtD
Cinacalcet—Vomiting—Azathioprine—systemic scleroderma	0.000727	0.00181	CcSEcCtD
Cinacalcet—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000724	0.00181	CcSEcCtD
Cinacalcet—Rash—Azathioprine—systemic scleroderma	0.000721	0.0018	CcSEcCtD
Cinacalcet—Dermatitis—Azathioprine—systemic scleroderma	0.00072	0.0018	CcSEcCtD
Cinacalcet—Depression—Methotrexate—systemic scleroderma	0.00072	0.00179	CcSEcCtD
Cinacalcet—Headache—Azathioprine—systemic scleroderma	0.000716	0.00179	CcSEcCtD
Cinacalcet—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00178	CcSEcCtD
Cinacalcet—Dizziness—Leflunomide—systemic scleroderma	0.000714	0.00178	CcSEcCtD
Cinacalcet—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00176	CcSEcCtD
Cinacalcet—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000704	0.00176	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00175	CcSEcCtD
Cinacalcet—Immune system disorder—Prednisone—systemic scleroderma	0.0007	0.00175	CcSEcCtD
Cinacalcet—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000695	0.00173	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisone—systemic scleroderma	0.000693	0.00173	CcSEcCtD
Cinacalcet—Vomiting—Leflunomide—systemic scleroderma	0.000686	0.00171	CcSEcCtD
Cinacalcet—Hypersensitivity—Lisinopril—systemic scleroderma	0.000683	0.0017	CcSEcCtD
Cinacalcet—Dizziness—Mycophenolic acid—systemic scleroderma	0.000681	0.0017	CcSEcCtD
Cinacalcet—Rash—Leflunomide—systemic scleroderma	0.00068	0.0017	CcSEcCtD
Cinacalcet—Dermatitis—Leflunomide—systemic scleroderma	0.00068	0.0017	CcSEcCtD
Cinacalcet—Nausea—Azathioprine—systemic scleroderma	0.000679	0.00169	CcSEcCtD
Cinacalcet—Headache—Leflunomide—systemic scleroderma	0.000676	0.00169	CcSEcCtD
Cinacalcet—Malnutrition—Prednisone—systemic scleroderma	0.000675	0.00168	CcSEcCtD
Cinacalcet—Asthenia—Lisinopril—systemic scleroderma	0.000665	0.00166	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00166	CcSEcCtD
Cinacalcet—Pruritus—Lisinopril—systemic scleroderma	0.000656	0.00164	CcSEcCtD
Cinacalcet—Vomiting—Mycophenolic acid—systemic scleroderma	0.000655	0.00163	CcSEcCtD
Cinacalcet—Rash—Mycophenolic acid—systemic scleroderma	0.000649	0.00162	CcSEcCtD
Cinacalcet—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000649	0.00162	CcSEcCtD
Cinacalcet—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000645	0.00161	CcSEcCtD
Cinacalcet—Headache—Mycophenolic acid—systemic scleroderma	0.000645	0.00161	CcSEcCtD
Cinacalcet—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000642	0.0016	CcSEcCtD
Cinacalcet—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000642	0.0016	CcSEcCtD
Cinacalcet—Nausea—Leflunomide—systemic scleroderma	0.000641	0.0016	CcSEcCtD
Cinacalcet—Diarrhoea—Lisinopril—systemic scleroderma	0.000634	0.00158	CcSEcCtD
Cinacalcet—Anaemia—Prednisone—systemic scleroderma	0.000624	0.00156	CcSEcCtD
Cinacalcet—Angioedema—Prednisone—systemic scleroderma	0.000617	0.00154	CcSEcCtD
Cinacalcet—Dizziness—Lisinopril—systemic scleroderma	0.000613	0.00153	CcSEcCtD
Cinacalcet—Nausea—Mycophenolic acid—systemic scleroderma	0.000612	0.00152	CcSEcCtD
Cinacalcet—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00149	CcSEcCtD
Cinacalcet—Vomiting—Lisinopril—systemic scleroderma	0.00059	0.00147	CcSEcCtD
Cinacalcet—Immune system disorder—Methotrexate—systemic scleroderma	0.000585	0.00146	CcSEcCtD
Cinacalcet—Rash—Lisinopril—systemic scleroderma	0.000585	0.00146	CcSEcCtD
Cinacalcet—Convulsion—Prednisone—systemic scleroderma	0.000585	0.00146	CcSEcCtD
Cinacalcet—Dermatitis—Lisinopril—systemic scleroderma	0.000584	0.00146	CcSEcCtD
Cinacalcet—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00145	CcSEcCtD
Cinacalcet—Hypertension—Prednisone—systemic scleroderma	0.000583	0.00145	CcSEcCtD
Cinacalcet—Headache—Lisinopril—systemic scleroderma	0.000581	0.00145	CcSEcCtD
Cinacalcet—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00143	CcSEcCtD
Cinacalcet—Arthralgia—Prednisone—systemic scleroderma	0.000575	0.00143	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—systemic scleroderma	0.000575	0.00143	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000571	0.00142	CcSEcCtD
Cinacalcet—Malnutrition—Methotrexate—systemic scleroderma	0.000564	0.00141	CcSEcCtD
Cinacalcet—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000556	0.00139	CcSEcCtD
Cinacalcet—Nausea—Lisinopril—systemic scleroderma	0.000551	0.00137	CcSEcCtD
Cinacalcet—Infection—Prednisone—systemic scleroderma	0.000547	0.00136	CcSEcCtD
Cinacalcet—Nervous system disorder—Prednisone—systemic scleroderma	0.00054	0.00135	CcSEcCtD
Cinacalcet—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00134	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—systemic scleroderma	0.000535	0.00133	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—systemic scleroderma	0.000525	0.00131	CcSEcCtD
Cinacalcet—Anaemia—Methotrexate—systemic scleroderma	0.000521	0.0013	CcSEcCtD
Cinacalcet—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00129	CcSEcCtD
Cinacalcet—Rash—Mycophenolate mofetil—systemic scleroderma	0.000512	0.00128	CcSEcCtD
Cinacalcet—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000512	0.00128	CcSEcCtD
Cinacalcet—Headache—Mycophenolate mofetil—systemic scleroderma	0.000509	0.00127	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000502	0.00125	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—systemic scleroderma	0.000495	0.00123	CcSEcCtD
Cinacalcet—Cough—Methotrexate—systemic scleroderma	0.000492	0.00123	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—systemic scleroderma	0.000489	0.00122	CcSEcCtD
Cinacalcet—Dyspepsia—Prednisone—systemic scleroderma	0.000485	0.00121	CcSEcCtD
Cinacalcet—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000483	0.0012	CcSEcCtD
Cinacalcet—Myalgia—Methotrexate—systemic scleroderma	0.00048	0.0012	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—systemic scleroderma	0.00048	0.0012	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—systemic scleroderma	0.00048	0.0012	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—systemic scleroderma	0.000479	0.00119	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000477	0.00119	CcSEcCtD
Cinacalcet—Fatigue—Prednisone—systemic scleroderma	0.000475	0.00118	CcSEcCtD
Cinacalcet—Constipation—Prednisone—systemic scleroderma	0.000471	0.00117	CcSEcCtD
Cinacalcet—Infection—Methotrexate—systemic scleroderma	0.000457	0.00114	CcSEcCtD
Cinacalcet—Nervous system disorder—Methotrexate—systemic scleroderma	0.000451	0.00113	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00045	0.00112	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—systemic scleroderma	0.000447	0.00111	CcSEcCtD
Cinacalcet—Anorexia—Methotrexate—systemic scleroderma	0.000439	0.00109	CcSEcCtD
Cinacalcet—Urticaria—Prednisone—systemic scleroderma	0.000438	0.00109	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—systemic scleroderma	0.000435	0.00109	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—systemic scleroderma	0.000435	0.00109	CcSEcCtD
Cinacalcet—Hypotension—Methotrexate—systemic scleroderma	0.00043	0.00107	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000419	0.00105	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—systemic scleroderma	0.000413	0.00103	CcSEcCtD
Cinacalcet—Dyspnoea—Methotrexate—systemic scleroderma	0.00041	0.00102	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisone—systemic scleroderma	0.000406	0.00101	CcSEcCtD
Cinacalcet—Dyspepsia—Methotrexate—systemic scleroderma	0.000405	0.00101	CcSEcCtD
Cinacalcet—Decreased appetite—Methotrexate—systemic scleroderma	0.0004	0.000998	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000397	0.000991	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—systemic scleroderma	0.000397	0.00099	CcSEcCtD
Cinacalcet—Asthenia—Prednisone—systemic scleroderma	0.000395	0.000985	CcSEcCtD
Cinacalcet—Pruritus—Prednisone—systemic scleroderma	0.00039	0.000972	CcSEcCtD
Cinacalcet—Diarrhoea—Prednisone—systemic scleroderma	0.000377	0.00094	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000376	0.000939	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—systemic scleroderma	0.000366	0.000912	CcSEcCtD
Cinacalcet—Dizziness—Prednisone—systemic scleroderma	0.000364	0.000908	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—systemic scleroderma	0.000364	0.000907	CcSEcCtD
Cinacalcet—Body temperature increased—Methotrexate—systemic scleroderma	0.000364	0.000907	CcSEcCtD
Cinacalcet—Vomiting—Prednisone—systemic scleroderma	0.00035	0.000873	CcSEcCtD
Cinacalcet—Rash—Prednisone—systemic scleroderma	0.000347	0.000866	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—systemic scleroderma	0.000347	0.000865	CcSEcCtD
Cinacalcet—Headache—Prednisone—systemic scleroderma	0.000345	0.00086	CcSEcCtD
Cinacalcet—Hypersensitivity—Methotrexate—systemic scleroderma	0.000339	0.000846	CcSEcCtD
Cinacalcet—Asthenia—Methotrexate—systemic scleroderma	0.00033	0.000824	CcSEcCtD
Cinacalcet—Nausea—Prednisone—systemic scleroderma	0.000327	0.000816	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—systemic scleroderma	0.000326	0.000812	CcSEcCtD
Cinacalcet—Diarrhoea—Methotrexate—systemic scleroderma	0.000315	0.000785	CcSEcCtD
Cinacalcet—Dizziness—Methotrexate—systemic scleroderma	0.000304	0.000759	CcSEcCtD
Cinacalcet—Vomiting—Methotrexate—systemic scleroderma	0.000293	0.00073	CcSEcCtD
Cinacalcet—Rash—Methotrexate—systemic scleroderma	0.00029	0.000724	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—systemic scleroderma	0.00029	0.000723	CcSEcCtD
Cinacalcet—Headache—Methotrexate—systemic scleroderma	0.000288	0.000719	CcSEcCtD
Cinacalcet—Nausea—Methotrexate—systemic scleroderma	0.000273	0.000682	CcSEcCtD
